NAFDAC's 5+5 Policy Boosts Nigeria's Pharmaceutical Sector

The National Agency for Food and Drug Administration and Control (NAFDAC) has reported that its 5+5 policy, introduced in 2018, is yielding significant results in Nigeria's pharmaceutical sector. Director General Prof.

Mojisola Christianah Adeyeye highlighted the positive impact of this strategy during a courtesy visit from the Indonesian Ambassador to Nigeria, Bambang Suharto. The policy aims to promote local pharmaceutical production and has successfully attracted foreign investors to establish manufacturing plants in Nigeria.

Prof. Adeyeye noted that Nigeria is set to attain World Health Organization maturity level 3 with a recertification expected in 2025, which positions the country as a favorable destination for pharmaceutical investments.

NAFDAC operates a state-of-the-art biological vaccine laboratory in Yaba, Lagos, enhancing Nigeria's regulatory capabilities within Sub-Saharan Africa. Prof.

Adeyeye reaffirmed NAFDAC's commitment to the 5+5 policy and expressed readiness to support prospective investors looking to establish manufacturing facilities in Nigeria.